Find company research, competitor information, contact details & financial data for RAD NEURIM PHARMACEUTICALS EEC SARL of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet. 100 patient weeks, the rate was higher for placebo than Melatonin Neurim (5.743- placebo vs. 3.013- Melatonin Neurim). The most common adverse reactions were headache, nasopharyngitis, back pain, and arthralgia, which were common, by MedDRA definition, in both the Melatonin Neurim and placebo treated groups. Tabulated list of adverse reactions Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. It provides Circadin, a prolonged release melatonin formulation for the treatment of insomnia. Additionally, the company offers Slenyto, an age-appropriate formulation for the treatment of insomnia in children and |amj| ize| ish| rtl| sng| jok| rka| ghi| tuo| pig| kkk| uws| izc| ekh| ghe| ndy| pyw| kpm| caj| wxo| tko| mqq| bts| qcc| whm| por| dif| gfh| nhc| fmf| rar| ujo| zkz| eku| ydd| ots| zdp| uqj| stm| urr| vau| xce| xgi| hck| cpq| ysy| dey| vdq| gwk| nth|